A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
第一作者:
Mi Jeong,Hong
第一单位:
Departments of Biochemistry and Cell Biology, Kyungpook National University Medical Center, Daegu, Republic of Korea.;Cell and Matrix Research Institute, Kyungpook National University Medical Center, Daegu, Republic of Korea.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结合部位(Binding Sites);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因型(Genotype);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);微RNAs(MicroRNAs);中年人(Middle Aged);紫杉酚(Paclitaxel);多态性, 单核苷酸(Polymorphism, Single Nucleotide);原癌基因蛋白质c-ets-2(Proto-Oncogene Protein c-ets-2)
DOI
10.18632/oncotarget.7433
PMID
26893365
发布时间
2018-11-13
- 浏览39

Oncotarget
15948-58页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文